An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models

Introduction: In the presence of competing risks, using of cumulative incidence function is important from the health economic evaluation point of view. This study aimed to use this function for determining the risk factors of competing events of colon and rectal cancers in metastatic patients.Mater...

Full description

Bibliographic Details
Main Authors: Mohammad Asghari Jafarabadi, Seyed Momene Mohammadi, Ebrahim Hajizadeh, Seyed Reza Fatemi
Format: Article
Language:fas
Published: Semnan Univeristy of Medical Sciences 2012-12-01
Series:Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān
Subjects:
Online Access:http://koomeshjournal.ir/browse.php?a_id=1583&sid=1&slc_lang=fa
id doaj-abbb5fd1fea84c0bbf4f633146969fa7
record_format Article
spelling doaj-abbb5fd1fea84c0bbf4f633146969fa72020-11-24T22:56:19ZfasSemnan Univeristy of Medical SciencesMajallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān1608-70462012-12-01142207214An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence modelsMohammad Asghari JafarabadiSeyed Momene MohammadiEbrahim HajizadehSeyed Reza FatemiIntroduction: In the presence of competing risks, using of cumulative incidence function is important from the health economic evaluation point of view. This study aimed to use this function for determining the risk factors of competing events of colon and rectal cancers in metastatic patients.Materials and Methods: In this survival study, data including age at diagnosis, sex, marital status, Body Mass Index (BMI), morphology of cancer, tumor size, tumor grade and pathological stage were gathered from the Research Center for Gastroenterology and Liver Diseases, Shaheed Beheshti University of Medical Sciences, Tehran for 94 metastatic colorectal cancer patients. Using a regression model based on the cumulative incidence function, parameters and tests of significance were obtained utilizing the R 2.13.1 software.Results: Five-year survival for metastatic patients with colon and rectal cancer, were 46.79% and 65.58% respectively, and the cumulative incidences were computed as .8 and 1.0 during a 100 months period, respectively. In the univariate and multivariate model, marital status in patients with colon cancer and in the univariate model, BMI and morphology were significant risk factors for rectal cancer.Conclusion: Using of modeling based on cumulative incidence function is recommended as a model to study the risk factor of colon and rectal cancers due to its optimal characteristicshttp://koomeshjournal.ir/browse.php?a_id=1583&sid=1&slc_lang=faColonColonic neoplasmsRectal neoplasmsRectumNeoplasm metastasisSurvival rate
collection DOAJ
language fas
format Article
sources DOAJ
author Mohammad Asghari Jafarabadi
Seyed Momene Mohammadi
Ebrahim Hajizadeh
Seyed Reza Fatemi
spellingShingle Mohammad Asghari Jafarabadi
Seyed Momene Mohammadi
Ebrahim Hajizadeh
Seyed Reza Fatemi
An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models
Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān
Colon
Colonic neoplasms
Rectal neoplasms
Rectum
Neoplasm metastasis
Survival rate
author_facet Mohammad Asghari Jafarabadi
Seyed Momene Mohammadi
Ebrahim Hajizadeh
Seyed Reza Fatemi
author_sort Mohammad Asghari Jafarabadi
title An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models
title_short An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models
title_full An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models
title_fullStr An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models
title_full_unstemmed An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models
title_sort evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models
publisher Semnan Univeristy of Medical Sciences
series Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān
issn 1608-7046
publishDate 2012-12-01
description Introduction: In the presence of competing risks, using of cumulative incidence function is important from the health economic evaluation point of view. This study aimed to use this function for determining the risk factors of competing events of colon and rectal cancers in metastatic patients.Materials and Methods: In this survival study, data including age at diagnosis, sex, marital status, Body Mass Index (BMI), morphology of cancer, tumor size, tumor grade and pathological stage were gathered from the Research Center for Gastroenterology and Liver Diseases, Shaheed Beheshti University of Medical Sciences, Tehran for 94 metastatic colorectal cancer patients. Using a regression model based on the cumulative incidence function, parameters and tests of significance were obtained utilizing the R 2.13.1 software.Results: Five-year survival for metastatic patients with colon and rectal cancer, were 46.79% and 65.58% respectively, and the cumulative incidences were computed as .8 and 1.0 during a 100 months period, respectively. In the univariate and multivariate model, marital status in patients with colon cancer and in the univariate model, BMI and morphology were significant risk factors for rectal cancer.Conclusion: Using of modeling based on cumulative incidence function is recommended as a model to study the risk factor of colon and rectal cancers due to its optimal characteristics
topic Colon
Colonic neoplasms
Rectal neoplasms
Rectum
Neoplasm metastasis
Survival rate
url http://koomeshjournal.ir/browse.php?a_id=1583&sid=1&slc_lang=fa
work_keys_str_mv AT mohammadasgharijafarabadi anevulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
AT seyedmomenemohammadi anevulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
AT ebrahimhajizadeh anevulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
AT seyedrezafatemi anevulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
AT mohammadasgharijafarabadi evulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
AT seyedmomenemohammadi evulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
AT ebrahimhajizadeh evulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
AT seyedrezafatemi evulationof5yearsurvivalofmetastaticcolonandrectalcancerpatientsusingcumulativeincidencemodels
_version_ 1725653878142140416